THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots. ExpertsContinue Reading
TUESDAY, Aug. 29, 2023 (HealthDay News) — Men’s testosterone levels remain pretty steady until age 70. After that, production of the male sex hormone starts to decline, new research indicates. This begs the question: Is testosterone loss among seniors really a function of the normal aging process? Or might itContinue Reading
MONDAY, July 17, 2023 (HealthDay News) — People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trialContinue Reading
TUESDAY, June 20, 2023 (HealthDay News) — In the face of an ongoing and widespread legal assault on transgender rights — one that threatens to cut off access to critical aspects of trans health care — a pair of new studies suggest that gender-affirming medical care is a lifesaving treatmentContinue Reading
FRIDAY, June 16, 2023 (HealthDay News) — Testosterone replacement therapy is safe for most men with heart problems who also have been diagnosed with a low testosterone disorder, a new clinical trial has concluded. The trial found that testosterone replacement did not raise these patients’ incidence of heart attack, strokeContinue Reading
TUESDAY, May 2, 2023 (HealthDay News) — The U.S. Food and Drug Administration is once again warning consumers to avoid muscle-building “supplements” that are anything but a safe alternative to steroids. In an advisory sent out last week, the agency said it continues to receive reports of serious side effectsContinue Reading
MONDAY, May 1, 2023 (HealthDay News) — Could a one-hour procedure that involves zapping a part of the intestines mean no more insulin for millions of folks with type 2 diabetes? Maybe, according to a small study scheduled for presentation next week at the Digestive Disease Week meeting in Chicago.Continue Reading
MONDAY, March 20, 2023 (HealthDay News) — Do you ever wonder why you typically feel hungry when it’s time for dinner? Researchers say that’s not just a habit, but a physiological drive, with the human body able to predict the timing of regular meals. “We often get hungry around theContinue Reading
FRIDAY, March 17, 2023 (HealthDay News) – Sanofi Inc. on Thursday became the third company to announce it will slash prices on its insulin products. The French company announced that it will cut prices by 78% and cap out-of-pocket charges for its insulin, brand named Lantus, at $35 per month.Continue Reading
TUESDAY, March 14, 2023 (HealthDay News) — Novo Nordisk Inc. on Tuesday became the third drug company to say it will slash prices on some of its insulin products. Starting in January 2024, there will be a 75% price cut for NovoLog and NovoLog Mix 70/30, while Novolin and LevemirContinue Reading